251 related articles for article (PubMed ID: 29488817)
1. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
2. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
3. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.
Kunckler M; Schumacher F; Kenfack B; Catarino R; Viviano M; Tincho E; Tebeu PM; Temogne L; Vassilakos P; Petignat P
Cancer Med; 2017 Jul; 6(7):1752-1761. PubMed ID: 28580596
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
6. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
7. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
BMC Cancer; 2017 Nov; 17(1):791. PubMed ID: 29178896
[TBL] [Abstract][Full Text] [Related]
8. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
9. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
[TBL] [Abstract][Full Text] [Related]
10. [Perspective of cervical cancer prevention and control in developing countries and areas].
Qiao YL
Chin J Cancer; 2010 Jan; 29(1):1-3. PubMed ID: 20038301
[TBL] [Abstract][Full Text] [Related]
11. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
Xie Y; Tan X; Shao H; Liu Q; Tou J; Zhang Y; Luo Q; Xiang Q
BMC Public Health; 2017 Jan; 17(1):118. PubMed ID: 28122530
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus screening and cervical cancer prevention.
Sasieni PD
J Am Med Womens Assoc (1972); 2000; 55(4):216-9. PubMed ID: 10935355
[TBL] [Abstract][Full Text] [Related]
14. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in low- and middle-income countries.
Ditzian LR; David-West G; Maza M; Hartmann B; Shirazian T; Cremer M
Mt Sinai J Med; 2011; 78(3):319-26. PubMed ID: 21598259
[TBL] [Abstract][Full Text] [Related]
17. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
[TBL] [Abstract][Full Text] [Related]
18. The next steps in cervical screening.
Sankaranarayanan R; Qiao YL; Keita N
Womens Health (Lond); 2015 Mar; 11(2):201-12. PubMed ID: 25776294
[TBL] [Abstract][Full Text] [Related]
19. Screening for cervical cancer and human papilloma virus: Indian context.
Deodhar KK
Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]